Xylem Inc (XY6)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 97.87 |
|---|---|
| 52-week range | 87.72 – 133.15 |
| Return, 1 month / 3 months | +2.7% / −4.0% |
| Return, 1 year / 3 years | −21.5% / +12.5% |
| Trend | Below its 200-day average |
| RSI (14) | 65 |
| Volatility (1 year) | 26.5% |
| Worst drawdown (1 year) | -31.7% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Xylem Inc is a water technology company that designs and supplies equipment for moving, treating, testing and measuring water. Its products include pumps, treatment systems, meters and analytical instruments used in wastewater, drinking water and industrial processes. Customers include municipal water utilities, industrial plants and building operators. The company is based in the United States and serves markets around the world through several established product brands.
The shares are listed on the XETRA Stock Exchange in Germany under the code XY6, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Xylem Inc (XY6) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 97.87 on 23 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 427 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 21.5% and over the last three months it fell 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 38 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.6% | ||
| From 52-week high | -25.8% | ||
| Momentum | 37 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.0% | ||
| 6-month return | -5.2% | ||
| 12-month return, skipping the last month | -23.6% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 26.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.7% | ||
| Liquidity | 38 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 58 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +4.9% |
|---|---|
| 1 month | +2.7% |
| 3 months | −4.0% |
| 6 months | −5.2% |
| 1 year | −21.5% |
| 3 years | +12.5% |
| 5 years | −6.1% |
Signals
| 50-day / 200-day average | 93.49 / 101.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.94 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Aug 2026 | USD 0.3825 |
| 28 May 2026 | USD 0.3825 |
| 24 Feb 2026 | USD 0.3825 |
| 25 Nov 2025 | USD 0.3558 |
| 28 Aug 2025 | USD 0.3558 |
| 29 May 2025 | USD 0.3558 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.